Loading...

BeiGene, Ltd.

BGNE•NASDAQ
Healthcare
Biotechnology
$184.71
$0.90(0.49%)

BeiGene, Ltd. (BGNE) Stock Chart & Performance Analysis

Explore BeiGene, Ltd.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-18.53%
5-Day Change
-15.11%
1-Month Change
0.49%
3-Month Change
-10.33%
6-Month Change
17.66%
Year-to-Date (YTD) Change
0.39%
1-Year Change
19.14%
3-Year Change
-23.86%
5-Year Change
20.34%
All-Time (Max) Change
552.22%

Analyzing BeiGene, Ltd. (BGNE) Trends Across Multiple Time Frames

BeiGene, Ltd. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. BeiGene, Ltd. stock shows -18.53% 1-day change, indicating low volatility, while its 5-day change of -15.11% suggests a broader trend. Over a 1-month period, a 0.49% rise could signal a pushback, whereas a 3-month decline of -10.33% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 17.66% and a YTD rise of 0.39% might concern investors, but a 1-year gain of 19.14% and a 3-year drop of -23.86% could indicate resilience. The 5-year surge of 20.34% highlights strong historical growth, while the all-time return of 552.22% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;